Streptococcus milleri group infection associated with digestive fistula in patients with vascular graft: Report of seven cases and review

Infection

Volumn 35, Issue 3, 2007, Pages 182-185

  Bonnet, E P ^a   Arista, S ^a   Archambaud, M ^a   Boot, B ^a   Clave, D ^a   Massip, P ^a   Marchou, B ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; CEPHALOSPORIN DERIVATIVE; LACTAM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE;

ABDOMINAL PAIN; ADULT; AGED; AORTA GRAFT; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; BLOOD VESSEL GRAFT; CAVA VEIN; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM HEMORRHAGE; FEMALE; FEVER; GRAFT INFECTION; HUMAN; INTESTINE FISTULA; MALE; MEDICAL LITERATURE; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MILLERI;

AGED; ANTI-INFECTIVE AGENTS; BETA-LACTAMS; DIGESTIVE SYSTEM FISTULA; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS MILLERI GROUP; VASCULAR FISTULA;

EID: 34250673913     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-6040-0     Document Type: Article

References (33)

1. Whiley RA, Beighton D: Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius and Streptococcus anginosus as distinct species. Int J Syst Bacteriol 1991; 41: 1-5.
2. Poole PM, Wilson G: Occurrence and cultural features of Streptococcus milleri in various body sites. J Clin Pathol 1979; 32: 764-768.
3. Gossling J: Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 1988; 10: 257-285.
4. Whitworth JM: Lancefield group F and related streptococci. J Med Microbiol 1990; 33: 135-151.
5. Jacobs JA, Pietersen HG, Stobberingh EE, Soeters PB: Bacteremia involving the "Streptococcus milleri" group; analysis of 19 cases. Clin Infect Dis 1994; 19: 704-713.
6. Bert F, Bariou-Lancelin M, Lambert-Zechovsky N: Clinical significance of bacteremia involving the "Streptococcus milleri" group: 51 cases and review. Clin Infect Dis 1998; 127: 385-387.
7. Murray HW, Gross KC, Masur H, Roberts RB: Serious infections caused by Streptococcus milleri. Am J Med 1978; 64: 759-764.
8. Van der Auwera P: Clinical significance of Streptococcus milleri. Eur J Clin Microbiol 1985; 4: 386-390.
9. Kambal AM: Isolation of Streptococcus milleri from clinical specimens. J Infect 1987; 14: 217-223.
10. Admon D, Ephros MA, Gavish D, Raz R: Infection with Streptococcus milleri. J Infect 1987; 14: 55-60.
11. Singh KP, Morris A, Lang SDR, Mc Culloch DM, Bremmer DA. Clinical significant Streptococcus anginosus (Streptococcus milleri) infections: a review of 186 cases. N Z Med J 1988; 101: 813-816.
12. Wagner KW, Schon R, Schumacher M, Schmelzeisen R, Schulze D: Case report: brain and liver abscesses caused by oral infection with Streptococcus intermedius. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: e21.
13. Molina JM, Leport C, Bure A, Wolff M, Michon C, Vilde JL: Clinical and bacterial features of infection by Streptococcus milleri. Scand J Infect Dis 1991; 11: 659-666.
14. Whiley A, Beighton D, Winstanley TG, Fraser HY, Hardie JM: Streptococcus intermedius, Streptococcus constellatus, Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 1992; 30: 243-244
15. Corredoira J, Casariego E, Moreno C, Villanueva L, Lopez, Varela J, Rodriguez A, Alonso P, Coira A: Prospective study of Streptococcus milleri hepatic abscess. Eur J Clin Microbiol Infect Dis 1998; 17: 556-560.
16. Yamamoto M, Fukushima T, Ohshiro S, Go Y, Tsugu H, Kono K, Tomonaga M: Brain abscess caused by Streptococcus intermedius. Surg Neurol 1999; 51: 219-222.
17. Porta G, Rodriguez-Carballeira M, Gomez L, Sallavert M, Freixas N, Xercavins M, Garau J: Thoracic infection caused by Streptococcus milleri. Eur Respir J 1998; 12: 357-362.
18. Nagashima H, Takao A, Maeda N: Abscess forming ability of Streptococcus milleri group: synergistic effect with Fusobacterium nucleatum. Microbiol Immunol 1999; 43: 207-216.
19. Bunt TJ: Synthetic vascular graft infections. Surgery 1983; 93: 739-743.
20. Castelli P, Caronno R, Ferrarese S, Mantovani V, Piffaretti G, Tozzi M, Lomazzi C, Rivolta N, Sala A: New trends in prosthesis infection in cardiovascular surgery. Surg Infect (Larchmt) 2006; 7 (Suppl 2): S45-S457.
21. Lorentzen JE, Nielsen Om, Arendrup H, Kimose HH, Bille S, Andersen J, Jensen J, Jacobsen F, Roder OC: Vascular graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 1985; 98: 81-86.
22. Costantino MJ: Recurent aortic infection following descending thoracic aorta to femoral artery bypass. J Cardiovasc Surg 1991; 32: 477-481.
23. O'Connor S, Andrew P, Batt M, Becquemin JP: A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006; 44: 38-45.
24. Sierra J, Kalangos A, Faidutti B, Christenson JT: Aorto-enteric fistula is a serious complication to aortic surgery. Modern trends in diagnosis and therapy. Cardiovasc Surg 2003; 11: 185-188.
25. Casariego E, Rodriguez A, Corredoira JC, Alonso P, Coira A, Bal M, Lopez MJ, Varela J: Prospective study of Streptococcus milleri bacteremia. Eur J Clin Microbiol Infect Dis 1996; 15: 194-200.
26. Salavert M, Gomez L, Rodriguez-Caballeira M, Xercavins M, Freixas N, Garau J: Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci. Eur J Clin Microbiol Infect Dis 1996; 15: 365-371.
27. Harris KA, Kozak R, Caroll SE, Meads GE, Sweeney JP: Confirmation of infection of an aortic graft. J Cardiovasc Surg (Torino) 1989; 30: 230-232.
28. Fox ND: Mycotic aneurysm of the abdominal aorta due to Streptococcus milleri. J R Coll Surg Edinb 1979; 24: 225-226.
29. Willcox MDP, Knox KW: Surface-associated properties of Streptococcus milleri group strains and their potential relation to pathogenesis. J Med Microbiol 1990; 31: 259-270.
30. Kanamori S, Kusano N, Shinzato T, Saito A: The role of the capsule of the Streptococcus milleri group in its pathogenicity. J infect Chemoter 2004; 10: 105-109.
31. Eggers S, Beuth J: Etiology and antibiotic susceptibility of blood stream Streptococcus sp. Int J Med Microbiol Parasitol Infect Dis 1992; 276: 521-529.
32. Horton WA, Drucker DB, Jacob AE, Hillier VF: Susceptibility of sixty-five non-oral clinical isolates of the Streptococcus milleri group. Microbios 1992; 71: 125-131.
33. Aracil B, Gomez-Garces JL, Alos JI: A study of susceptibility of 100 clinical isolatesbelonging to the Streptococcus milleri group to 16 cephalosporins. J Antimicrob Chemother 1999; 276: 399-402.